Pharmaceutical Technology Europe-12-01-2008

Pharmaceutical Technology Europe

How has pharmaceutical manufacturing validation influenced analytical instrument qualification during the last 20 years and what are the emerging trends for the future?

Pharmaceutical Technology Europe
Regulatory Report

December 01, 2008

The closing date for comments to be received by the US Pharmacopeia (USP) for proposed revisions to Chapter <231>, which deals with analysis of heavy metals, is 15 December 2008. The USP has been working towards for approximately 4 years and the task has not been easy.

Pharmaceutical Technology Europe

Microcrystalline cellulose is the main excipient used in the industrial manufacture of pellets by extrusion/spheronization, but pellets containing this spheronizing aid do not readily disintegrate and are expensive.

Pharmaceutical Technology Europe

New research suggests calcium carbonate tablets are stronger and less porous when manufactured using a wet, rather than a dry, granulation process.

Pharmaceutical Technology Europe
Spotlight

December 01, 2008

Hundreds of pharma&#150;biotech deals have been announced during 2008 and many of these probably began at biopartnering conferences. Susan Aldridge examines some of this year's big buyouts and mergers.

Pharmaceutical Technology Europe
Biotech business

December 01, 2008

It is a universally acknowledged truth that a biotech start-up in possession of little fortune must be in want of venture capital (VC). Perhaps less well acknowledged, however, is that VC investors operate in a way consistent with being rational economic entities...

Pharmaceutical Technology Europe
Manufacturing & Processing

December 01, 2008

Although realized in 1983, ASTM's standrad test method for determining bacterial retention of membrane filters used for liquid filtration is still hugely beneficial to today's pharmaceutical industry.

Business Talk
Pharmaceutical Technology Europe

December 01, 2008

TranScrip Partners' Flic Gabbay explains why an approach that provides expertise on an 'as needed basis' is flourishing.

Pharmaceutical Technology Europe
Viewpoint

December 01, 2008

...the new administration is not anti-science or even anti-industry. It just wants lower prices.

Pharmaceutical Technology Europe
Business

December 01, 2008

You don't have to spend any time in the company of its chairman to see that there is no other Big Pharma company like Servier.